AgomAb Therapeutics N.V. American Depositary Shares
NASDAQ:AGMBBiotechnology
+$0.25 today
- Market cap
- $286.62M
- Beta
- 2.62
- P/E (TTM)
- -7.1
- EPS (TTM)
- -$1.28
Volume 0.13M
Average 0.14M
AGMB Common Stock
The par or stated value of issued common shares, plus paid-in capital where reported together.
AgomAb Therapeutics N.V. American Depositary SharesNASDAQ: AGMB
Common Stock · Q3 FY2025 · quarter ended Sep 2025
Common stock of €223.07M in Q3 FY2025
Q3 FY2025 common stock was €223.07M.
Context
- Common stock amounted to 134.7% of total assets at the end of Q3 FY2025.
Sources:Balance SheetText generated from reported figures; not investment advice.
Common Stock history
Currency unavailable · from the balance sheet
No Common Stock data reported for this period type.
Common Stock vs competitors
How AGMB compares with its peers on the latest reported figures
- Peers report in different currencies, so common stock is compared through growth and share of total assets rather than absolute size.
- Common stock amounts to 134.7% of total assets for AGMB, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
AGMBAgomAb Therapeutics N.V. American Depositary Shares | Sep 2025 | €223.07M EUR | — | — | 134.7% |
| Mar 2026 | $29K USD | -3.3% | -1.2% | 0.0% | |
ALMSAlumis Inc. Common Stock | Jun 2026 | $12K USD | +20.0% | +108.0% | 0.0% |
| Mar 2026 | $5K USD | +66.7% | +18.6% | 0.0% | |
| Mar 2026 | $1K USD | +0.0% | +0.0% | 0.0% | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
| Peer median (excluding AGMB) | — | +10.0% | +9.3% | 0.0% | |
Competitors are the stored peer set for AGMB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
AgomAb Therapeutics N.V. American Depositary Shares
NASDAQ:AGMB
Intrinsic Alpha fair value
Locked
Current Price
$5.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.